chartexchange

BEAM
Beam Therapeutics Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 11:56:06 AM EST
20.75USD-0.907%(-0.19)796,361
Pre-marketNov 17, 2026 9:25:30 AM EST
20.89USD-0.226%(-0.05)
20.70Bid20.84Ask0.14Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$20.94
Beta
2.24
52-Week High
$38.26 2026-07-07
52-Week Low
$20.23 2025-11-20
SMA 50
$24.97
SMA 200
$27.84
Avg. Vol 10D
2.06M
Avg. Vol 30D
1.97M
Avg. Vol 90D
1.90M
Relative Vol
0.39
103.50M
88.07M
26,082,937
0.4200%
340
BEAM Profile

beam therapeutics is developing precision genetic medicines for serious diseases. co-founded by scientific pioneers known for advancing crispr gene editing, we're the first company to pursue development of new therapies using crispr base editing technology. we aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. who we are beam is creating precision genetic medicines through base editing why we do it our dream is to provide life-long cures for patients suffering from serious diseases who we are and how we work together the beam team:  a community of fearless innovators  rigorous and honest in our research  listening with open minds  committed to each other

BEAM Performance
PeriodPriceDateChangeBeta
1W25.152026-11-10-17.87%3.408
1M23.472026-10-16-11.99%2.378
3M27.102026-08-17-23.78%2.671
6M26.812026-05-18-22.95%2.357
1Y22.022025-11-17-6.20%2.239
2Y24.122024-11-18-14.36%—
5Y88.922021-11-17-76.77%2.049
BEAM Stock Summary

Beam Therapeutics Inc. Common Stock (NASDAQ:BEAM) stock price today is $20.66, and today's volume is 770,170. BEAM is down 1.357% today. The 30 day average volume is 1.97M. BEAM market cap is $2.14B with 103.50M shares outstanding.